Perrigo Company plc (PRGO) vs Supernus Pharmaceuticals, Inc. (SUPN)
- Perrigo Company plc PRGO 16.63 +0.91%
- Supernus Pharmaceuticals, Inc. SUPN 37.88 −4.27%
Perrigo Company plc and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc and Supernus Pharmaceuticals, Inc. are of similar size ($2.3B and $2.3B). Supernus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 24.9% against −4.19%. Supernus Pharmaceuticals, Inc. has the higher net margin (−13.2% vs −41.9%) and the higher return on invested capital (−12.4% vs −18.1%). Across the 19 metrics below, Supernus Pharmaceuticals, Inc. leads on 12 and Perrigo Company plc on 7.
Valuation
Profitability
| Metric | PRGO | SUPN | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 33.26% | 88.07% | 53.94% |
| Operating margin | (37.71%) | (15.71%) | 0.00% |
| Net margin | (41.85%) | (13.23%) | 0.00% |
| Free cash flow margin | 2.88% | 2.21% | 0.00% |
| Return on equity | (49.65%) | (10.49%) | (0.40%) |
| Return on assets | (19.60%) | (7.82%) | (3.32%) |
| Return on invested capital | (18.06%) | (12.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack